nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevoflurane—ALB—Vandetanib—thyroid cancer	0.108	0.384	CbGbCtD
Sevoflurane—CYP2B6—Sorafenib—thyroid cancer	0.0662	0.236	CbGbCtD
Sevoflurane—CYP2B6—Doxorubicin—thyroid cancer	0.0402	0.143	CbGbCtD
Sevoflurane—CYP3A4—Vandetanib—thyroid cancer	0.0338	0.12	CbGbCtD
Sevoflurane—CYP3A4—Sorafenib—thyroid cancer	0.0203	0.0725	CbGbCtD
Sevoflurane—CYP3A4—Doxorubicin—thyroid cancer	0.0123	0.044	CbGbCtD
Sevoflurane—ND1—neck—thyroid cancer	0.00931	0.0485	CbGeAlD
Sevoflurane—GABRA3—neck—thyroid cancer	0.0075	0.0391	CbGeAlD
Sevoflurane—ND1—saliva-secreting gland—thyroid cancer	0.00726	0.0378	CbGeAlD
Sevoflurane—KCNK2—thyroid gland—thyroid cancer	0.00662	0.0345	CbGeAlD
Sevoflurane—KCNK10—head—thyroid cancer	0.00628	0.0327	CbGeAlD
Sevoflurane—KCNK9—head—thyroid cancer	0.00624	0.0325	CbGeAlD
Sevoflurane—ATP5D—saliva-secreting gland—thyroid cancer	0.00585	0.0305	CbGeAlD
Sevoflurane—ATP2C1—saliva-secreting gland—thyroid cancer	0.00577	0.0301	CbGeAlD
Sevoflurane—KCNK3—head—thyroid cancer	0.00567	0.0295	CbGeAlD
Sevoflurane—GABRQ—head—thyroid cancer	0.00505	0.0263	CbGeAlD
Sevoflurane—KCNA1—thyroid gland—thyroid cancer	0.00503	0.0262	CbGeAlD
Sevoflurane—GRIA1—head—thyroid cancer	0.00457	0.0238	CbGeAlD
Sevoflurane—ATP5D—trachea—thyroid cancer	0.00451	0.0235	CbGeAlD
Sevoflurane—KCNA1—head—thyroid cancer	0.00446	0.0232	CbGeAlD
Sevoflurane—ATP2C1—trachea—thyroid cancer	0.00445	0.0232	CbGeAlD
Sevoflurane—ND1—thyroid gland—thyroid cancer	0.00443	0.0231	CbGeAlD
Sevoflurane—GABRG3—head—thyroid cancer	0.00443	0.0231	CbGeAlD
Sevoflurane—GABRP—trachea—thyroid cancer	0.00437	0.0227	CbGeAlD
Sevoflurane—KCNK2—lymph node—thyroid cancer	0.00411	0.0214	CbGeAlD
Sevoflurane—ND1—head—thyroid cancer	0.00393	0.0205	CbGeAlD
Sevoflurane—GABRD—head—thyroid cancer	0.00366	0.0191	CbGeAlD
Sevoflurane—GABRA3—thyroid gland—thyroid cancer	0.00357	0.0186	CbGeAlD
Sevoflurane—ATP5D—thyroid gland—thyroid cancer	0.00357	0.0186	CbGeAlD
Sevoflurane—Hepatobiliary disease—Vandetanib—thyroid cancer	0.00353	0.00773	CcSEcCtD
Sevoflurane—GABRG1—head—thyroid cancer	0.00353	0.0184	CbGeAlD
Sevoflurane—ATP2C1—thyroid gland—thyroid cancer	0.00352	0.0184	CbGeAlD
Sevoflurane—GABRA6—head—thyroid cancer	0.00351	0.0183	CbGeAlD
Sevoflurane—GABRB1—head—thyroid cancer	0.00342	0.0178	CbGeAlD
Sevoflurane—Bradycardia—Vandetanib—thyroid cancer	0.00342	0.00747	CcSEcCtD
Sevoflurane—GABRA5—head—thyroid cancer	0.0034	0.0177	CbGeAlD
Sevoflurane—Haemoglobin—Vandetanib—thyroid cancer	0.00337	0.00737	CcSEcCtD
Sevoflurane—Haemorrhage—Vandetanib—thyroid cancer	0.00336	0.00733	CcSEcCtD
Sevoflurane—GABRE—trachea—thyroid cancer	0.00333	0.0174	CbGeAlD
Sevoflurane—Urinary tract disorder—Vandetanib—thyroid cancer	0.00331	0.00724	CcSEcCtD
Sevoflurane—Urethral disorder—Vandetanib—thyroid cancer	0.00329	0.00719	CcSEcCtD
Sevoflurane—GABRA3—head—thyroid cancer	0.00317	0.0165	CbGeAlD
Sevoflurane—ATP5D—head—thyroid cancer	0.00317	0.0165	CbGeAlD
Sevoflurane—ATP2C1—head—thyroid cancer	0.00313	0.0163	CbGeAlD
Sevoflurane—Cardiac disorder—Vandetanib—thyroid cancer	0.00311	0.00681	CcSEcCtD
Sevoflurane—GABRA4—head—thyroid cancer	0.00309	0.0161	CbGeAlD
Sevoflurane—GABRP—head—thyroid cancer	0.00306	0.016	CbGeAlD
Sevoflurane—Angiopathy—Vandetanib—thyroid cancer	0.00304	0.00665	CcSEcCtD
Sevoflurane—Mediastinal disorder—Vandetanib—thyroid cancer	0.00302	0.00661	CcSEcCtD
Sevoflurane—Urine abnormality—Epirubicin—thyroid cancer	0.00301	0.00658	CcSEcCtD
Sevoflurane—Arrhythmia—Vandetanib—thyroid cancer	0.003	0.00655	CcSEcCtD
Sevoflurane—Hypothermia—Epirubicin—thyroid cancer	0.00297	0.0065	CcSEcCtD
Sevoflurane—Body temperature decreased—Epirubicin—thyroid cancer	0.00297	0.0065	CcSEcCtD
Sevoflurane—Mental disorder—Vandetanib—thyroid cancer	0.00294	0.00643	CcSEcCtD
Sevoflurane—Malnutrition—Vandetanib—thyroid cancer	0.00292	0.00638	CcSEcCtD
Sevoflurane—Hypophosphataemia—Epirubicin—thyroid cancer	0.00287	0.00627	CcSEcCtD
Sevoflurane—Dysgeusia—Vandetanib—thyroid cancer	0.00286	0.00625	CcSEcCtD
Sevoflurane—Urine analysis abnormal—Epirubicin—thyroid cancer	0.00283	0.00619	CcSEcCtD
Sevoflurane—Urine abnormality—Doxorubicin—thyroid cancer	0.00278	0.00609	CcSEcCtD
Sevoflurane—Pancreatitis—Sorafenib—thyroid cancer	0.00277	0.00606	CcSEcCtD
Sevoflurane—ND1—lymph node—thyroid cancer	0.00275	0.0143	CbGeAlD
Sevoflurane—Body temperature decreased—Doxorubicin—thyroid cancer	0.00275	0.00601	CcSEcCtD
Sevoflurane—Hypothermia—Doxorubicin—thyroid cancer	0.00275	0.00601	CcSEcCtD
Sevoflurane—Hypophosphataemia—Doxorubicin—thyroid cancer	0.00265	0.0058	CcSEcCtD
Sevoflurane—GABRE—thyroid gland—thyroid cancer	0.00264	0.0137	CbGeAlD
Sevoflurane—Urine analysis abnormal—Doxorubicin—thyroid cancer	0.00262	0.00573	CcSEcCtD
Sevoflurane—GABRB2—head—thyroid cancer	0.00258	0.0135	CbGeAlD
Sevoflurane—GABRG2—head—thyroid cancer	0.00258	0.0135	CbGeAlD
Sevoflurane—Loss of consciousness—Vandetanib—thyroid cancer	0.00257	0.00561	CcSEcCtD
Sevoflurane—Cough—Vandetanib—thyroid cancer	0.00255	0.00557	CcSEcCtD
Sevoflurane—Convulsion—Vandetanib—thyroid cancer	0.00253	0.00553	CcSEcCtD
Sevoflurane—Hypertension—Vandetanib—thyroid cancer	0.00252	0.00551	CcSEcCtD
Sevoflurane—Chest pain—Vandetanib—thyroid cancer	0.00249	0.00544	CcSEcCtD
Sevoflurane—Renal failure—Sorafenib—thyroid cancer	0.00248	0.00542	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00247	0.0054	CcSEcCtD
Sevoflurane—Jaundice—Sorafenib—thyroid cancer	0.00246	0.00537	CcSEcCtD
Sevoflurane—Dry mouth—Vandetanib—thyroid cancer	0.00243	0.00532	CcSEcCtD
Sevoflurane—Hyperventilation—Epirubicin—thyroid cancer	0.00242	0.00529	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Sorafenib—thyroid cancer	0.00238	0.00521	CcSEcCtD
Sevoflurane—Oedema—Vandetanib—thyroid cancer	0.00238	0.00521	CcSEcCtD
Sevoflurane—GABRA2—head—thyroid cancer	0.00236	0.0123	CbGeAlD
Sevoflurane—GABRE—head—thyroid cancer	0.00234	0.0122	CbGeAlD
Sevoflurane—Nervous system disorder—Vandetanib—thyroid cancer	0.00234	0.00511	CcSEcCtD
Sevoflurane—Thrombocytopenia—Vandetanib—thyroid cancer	0.00233	0.0051	CcSEcCtD
Sevoflurane—Skin disorder—Vandetanib—thyroid cancer	0.00232	0.00506	CcSEcCtD
Sevoflurane—GABRA1—head—thyroid cancer	0.00228	0.0119	CbGeAlD
Sevoflurane—Haemoglobin—Sorafenib—thyroid cancer	0.00227	0.00497	CcSEcCtD
Sevoflurane—Haemorrhage—Sorafenib—thyroid cancer	0.00226	0.00495	CcSEcCtD
Sevoflurane—Hyperventilation—Doxorubicin—thyroid cancer	0.00224	0.0049	CcSEcCtD
Sevoflurane—GABRB3—thyroid gland—thyroid cancer	0.00224	0.0116	CbGeAlD
Sevoflurane—Urinary tract disorder—Sorafenib—thyroid cancer	0.00224	0.00489	CcSEcCtD
Sevoflurane—Albuminuria—Epirubicin—thyroid cancer	0.00223	0.00488	CcSEcCtD
Sevoflurane—Urethral disorder—Sorafenib—thyroid cancer	0.00222	0.00485	CcSEcCtD
Sevoflurane—ATP5D—lymph node—thyroid cancer	0.00222	0.0116	CbGeAlD
Sevoflurane—ATP2C1—lymph node—thyroid cancer	0.00219	0.0114	CbGeAlD
Sevoflurane—Amblyopia—Epirubicin—thyroid cancer	0.00216	0.00472	CcSEcCtD
Sevoflurane—Insomnia—Vandetanib—thyroid cancer	0.00216	0.00471	CcSEcCtD
Sevoflurane—Dyspnoea—Vandetanib—thyroid cancer	0.00213	0.00465	CcSEcCtD
Sevoflurane—Cardiac disorder—Sorafenib—thyroid cancer	0.0021	0.00459	CcSEcCtD
Sevoflurane—Albuminuria—Doxorubicin—thyroid cancer	0.00206	0.00451	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00206	0.0045	CcSEcCtD
Sevoflurane—Glycosuria—Epirubicin—thyroid cancer	0.00206	0.00449	CcSEcCtD
Sevoflurane—Angiopathy—Sorafenib—thyroid cancer	0.00205	0.00449	CcSEcCtD
Sevoflurane—Immune system disorder—Sorafenib—thyroid cancer	0.00204	0.00447	CcSEcCtD
Sevoflurane—Mediastinal disorder—Sorafenib—thyroid cancer	0.00204	0.00446	CcSEcCtD
Sevoflurane—Pain—Vandetanib—thyroid cancer	0.00204	0.00446	CcSEcCtD
Sevoflurane—Arrhythmia—Sorafenib—thyroid cancer	0.00202	0.00442	CcSEcCtD
Sevoflurane—Amblyopia—Doxorubicin—thyroid cancer	0.002	0.00436	CcSEcCtD
Sevoflurane—GABRB3—head—thyroid cancer	0.00198	0.0103	CbGeAlD
Sevoflurane—Mental disorder—Sorafenib—thyroid cancer	0.00198	0.00433	CcSEcCtD
Sevoflurane—Malnutrition—Sorafenib—thyroid cancer	0.00197	0.00431	CcSEcCtD
Sevoflurane—Dysgeusia—Sorafenib—thyroid cancer	0.00193	0.00422	CcSEcCtD
Sevoflurane—Glycosuria—Doxorubicin—thyroid cancer	0.0019	0.00416	CcSEcCtD
Sevoflurane—Body temperature increased—Vandetanib—thyroid cancer	0.00188	0.00412	CcSEcCtD
Sevoflurane—Bone disorder—Epirubicin—thyroid cancer	0.00184	0.00403	CcSEcCtD
Sevoflurane—Ventricular extrasystoles—Epirubicin—thyroid cancer	0.00184	0.00403	CcSEcCtD
Sevoflurane—Hyperbilirubinaemia—Epirubicin—thyroid cancer	0.00183	0.004	CcSEcCtD
Sevoflurane—Cough increased—Epirubicin—thyroid cancer	0.00182	0.00398	CcSEcCtD
Sevoflurane—Oliguria—Epirubicin—thyroid cancer	0.00181	0.00395	CcSEcCtD
Sevoflurane—Syncope—Sorafenib—thyroid cancer	0.00177	0.00386	CcSEcCtD
Sevoflurane—Loss of consciousness—Sorafenib—thyroid cancer	0.00173	0.00379	CcSEcCtD
Sevoflurane—Cough—Sorafenib—thyroid cancer	0.00172	0.00376	CcSEcCtD
Sevoflurane—Asthenia—Vandetanib—thyroid cancer	0.00171	0.00374	CcSEcCtD
Sevoflurane—Bone disorder—Doxorubicin—thyroid cancer	0.00171	0.00373	CcSEcCtD
Sevoflurane—Ventricular extrasystoles—Doxorubicin—thyroid cancer	0.00171	0.00373	CcSEcCtD
Sevoflurane—Hypertension—Sorafenib—thyroid cancer	0.0017	0.00372	CcSEcCtD
Sevoflurane—Hyperbilirubinaemia—Doxorubicin—thyroid cancer	0.00169	0.0037	CcSEcCtD
Sevoflurane—Pruritus—Vandetanib—thyroid cancer	0.00169	0.00369	CcSEcCtD
Sevoflurane—Cough increased—Doxorubicin—thyroid cancer	0.00168	0.00368	CcSEcCtD
Sevoflurane—Oliguria—Doxorubicin—thyroid cancer	0.00167	0.00366	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00167	0.00364	CcSEcCtD
Sevoflurane—Hiccups—Epirubicin—thyroid cancer	0.00167	0.00364	CcSEcCtD
Sevoflurane—Ventricular tachycardia—Epirubicin—thyroid cancer	0.00167	0.00364	CcSEcCtD
Sevoflurane—GABRA2—lymph node—thyroid cancer	0.00165	0.00861	CbGeAlD
Sevoflurane—Dermatitis contact—Epirubicin—thyroid cancer	0.00165	0.0036	CcSEcCtD
Sevoflurane—Dry mouth—Sorafenib—thyroid cancer	0.00164	0.00359	CcSEcCtD
Sevoflurane—GABRE—lymph node—thyroid cancer	0.00164	0.00853	CbGeAlD
Sevoflurane—Hyperkalaemia—Epirubicin—thyroid cancer	0.00164	0.00358	CcSEcCtD
Sevoflurane—Salivary hypersecretion—Epirubicin—thyroid cancer	0.00162	0.00354	CcSEcCtD
Sevoflurane—Anaphylactic shock—Sorafenib—thyroid cancer	0.00161	0.00352	CcSEcCtD
Sevoflurane—Shock—Sorafenib—thyroid cancer	0.00158	0.00346	CcSEcCtD
Sevoflurane—Nervous system disorder—Sorafenib—thyroid cancer	0.00158	0.00345	CcSEcCtD
Sevoflurane—Dizziness—Vandetanib—thyroid cancer	0.00158	0.00345	CcSEcCtD
Sevoflurane—Thrombocytopenia—Sorafenib—thyroid cancer	0.00157	0.00344	CcSEcCtD
Sevoflurane—Skin disorder—Sorafenib—thyroid cancer	0.00156	0.00341	CcSEcCtD
Sevoflurane—Hiccups—Doxorubicin—thyroid cancer	0.00154	0.00337	CcSEcCtD
Sevoflurane—Ventricular tachycardia—Doxorubicin—thyroid cancer	0.00154	0.00337	CcSEcCtD
Sevoflurane—Dermatitis contact—Doxorubicin—thyroid cancer	0.00152	0.00333	CcSEcCtD
Sevoflurane—Vomiting—Vandetanib—thyroid cancer	0.00152	0.00331	CcSEcCtD
Sevoflurane—Hyperkalaemia—Doxorubicin—thyroid cancer	0.00151	0.00331	CcSEcCtD
Sevoflurane—Rash—Vandetanib—thyroid cancer	0.0015	0.00329	CcSEcCtD
Sevoflurane—Dermatitis—Vandetanib—thyroid cancer	0.0015	0.00328	CcSEcCtD
Sevoflurane—Salivary hypersecretion—Doxorubicin—thyroid cancer	0.0015	0.00327	CcSEcCtD
Sevoflurane—Headache—Vandetanib—thyroid cancer	0.00149	0.00326	CcSEcCtD
Sevoflurane—ALB—lymph node—thyroid cancer	0.00149	0.00778	CbGeAlD
Sevoflurane—Hypertonia—Epirubicin—thyroid cancer	0.00146	0.00319	CcSEcCtD
Sevoflurane—Dyspnoea—Sorafenib—thyroid cancer	0.00143	0.00313	CcSEcCtD
Sevoflurane—CYP2E1—thyroid gland—thyroid cancer	0.00142	0.00741	CbGeAlD
Sevoflurane—Nausea—Vandetanib—thyroid cancer	0.00142	0.0031	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00139	0.00303	CcSEcCtD
Sevoflurane—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00138	0.00302	CcSEcCtD
Sevoflurane—Pain—Sorafenib—thyroid cancer	0.00137	0.00301	CcSEcCtD
Sevoflurane—Hypertonia—Doxorubicin—thyroid cancer	0.00135	0.00295	CcSEcCtD
Sevoflurane—Hepatic failure—Epirubicin—thyroid cancer	0.00135	0.00294	CcSEcCtD
Sevoflurane—CYP2B6—head—thyroid cancer	0.00134	0.007	CbGeAlD
Sevoflurane—Renal failure acute—Epirubicin—thyroid cancer	0.00131	0.00286	CcSEcCtD
Sevoflurane—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.00128	0.0028	CcSEcCtD
Sevoflurane—Urticaria—Sorafenib—thyroid cancer	0.00128	0.00279	CcSEcCtD
Sevoflurane—Body temperature increased—Sorafenib—thyroid cancer	0.00127	0.00278	CcSEcCtD
Sevoflurane—CYP2E1—head—thyroid cancer	0.00126	0.00657	CbGeAlD
Sevoflurane—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.00125	0.00273	CcSEcCtD
Sevoflurane—Hepatic failure—Doxorubicin—thyroid cancer	0.00124	0.00272	CcSEcCtD
Sevoflurane—Renal failure acute—Doxorubicin—thyroid cancer	0.00121	0.00265	CcSEcCtD
Sevoflurane—Hypersensitivity—Sorafenib—thyroid cancer	0.00118	0.00259	CcSEcCtD
Sevoflurane—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.00116	0.00253	CcSEcCtD
Sevoflurane—Asthenia—Sorafenib—thyroid cancer	0.00115	0.00252	CcSEcCtD
Sevoflurane—Cardiac arrest—Epirubicin—thyroid cancer	0.00115	0.00251	CcSEcCtD
Sevoflurane—Pruritus—Sorafenib—thyroid cancer	0.00114	0.00249	CcSEcCtD
Sevoflurane—Liver function test abnormal—Epirubicin—thyroid cancer	0.00112	0.00244	CcSEcCtD
Sevoflurane—Cardiac arrest—Doxorubicin—thyroid cancer	0.00106	0.00233	CcSEcCtD
Sevoflurane—Dizziness—Sorafenib—thyroid cancer	0.00106	0.00232	CcSEcCtD
Sevoflurane—Liver function test abnormal—Doxorubicin—thyroid cancer	0.00103	0.00226	CcSEcCtD
Sevoflurane—Pancreatitis—Epirubicin—thyroid cancer	0.00102	0.00224	CcSEcCtD
Sevoflurane—Vomiting—Sorafenib—thyroid cancer	0.00102	0.00223	CcSEcCtD
Sevoflurane—Rash—Sorafenib—thyroid cancer	0.00101	0.00222	CcSEcCtD
Sevoflurane—Dermatitis—Sorafenib—thyroid cancer	0.00101	0.00221	CcSEcCtD
Sevoflurane—Headache—Sorafenib—thyroid cancer	0.00101	0.0022	CcSEcCtD
Sevoflurane—Dysuria—Epirubicin—thyroid cancer	0.000977	0.00214	CcSEcCtD
Sevoflurane—Nausea—Sorafenib—thyroid cancer	0.000955	0.00209	CcSEcCtD
Sevoflurane—Pancreatitis—Doxorubicin—thyroid cancer	0.000948	0.00207	CcSEcCtD
Sevoflurane—Hyperglycaemia—Epirubicin—thyroid cancer	0.000943	0.00206	CcSEcCtD
Sevoflurane—Renal failure—Epirubicin—thyroid cancer	0.000916	0.002	CcSEcCtD
Sevoflurane—Jaundice—Epirubicin—thyroid cancer	0.000908	0.00199	CcSEcCtD
Sevoflurane—Conjunctivitis—Epirubicin—thyroid cancer	0.000906	0.00198	CcSEcCtD
Sevoflurane—Dysuria—Doxorubicin—thyroid cancer	0.000904	0.00198	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000881	0.00193	CcSEcCtD
Sevoflurane—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000872	0.00191	CcSEcCtD
Sevoflurane—Bradycardia—Epirubicin—thyroid cancer	0.000851	0.00186	CcSEcCtD
Sevoflurane—Renal failure—Doxorubicin—thyroid cancer	0.000847	0.00185	CcSEcCtD
Sevoflurane—Haemoglobin—Epirubicin—thyroid cancer	0.000841	0.00184	CcSEcCtD
Sevoflurane—Jaundice—Doxorubicin—thyroid cancer	0.00084	0.00184	CcSEcCtD
Sevoflurane—Conjunctivitis—Doxorubicin—thyroid cancer	0.000838	0.00183	CcSEcCtD
Sevoflurane—Hepatitis—Epirubicin—thyroid cancer	0.000836	0.00183	CcSEcCtD
Sevoflurane—Haemorrhage—Epirubicin—thyroid cancer	0.000836	0.00183	CcSEcCtD
Sevoflurane—Pharyngitis—Epirubicin—thyroid cancer	0.00083	0.00181	CcSEcCtD
Sevoflurane—Urinary tract disorder—Epirubicin—thyroid cancer	0.000826	0.00181	CcSEcCtD
Sevoflurane—Urethral disorder—Epirubicin—thyroid cancer	0.00082	0.00179	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000815	0.00178	CcSEcCtD
Sevoflurane—Bradycardia—Doxorubicin—thyroid cancer	0.000788	0.00172	CcSEcCtD
Sevoflurane—Haemoglobin—Doxorubicin—thyroid cancer	0.000778	0.0017	CcSEcCtD
Sevoflurane—Cardiac disorder—Epirubicin—thyroid cancer	0.000776	0.0017	CcSEcCtD
Sevoflurane—Haemorrhage—Doxorubicin—thyroid cancer	0.000774	0.00169	CcSEcCtD
Sevoflurane—Hepatitis—Doxorubicin—thyroid cancer	0.000774	0.00169	CcSEcCtD
Sevoflurane—Pharyngitis—Doxorubicin—thyroid cancer	0.000768	0.00168	CcSEcCtD
Sevoflurane—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000764	0.00167	CcSEcCtD
Sevoflurane—Angiopathy—Epirubicin—thyroid cancer	0.000759	0.00166	CcSEcCtD
Sevoflurane—Urethral disorder—Doxorubicin—thyroid cancer	0.000759	0.00166	CcSEcCtD
Sevoflurane—Immune system disorder—Epirubicin—thyroid cancer	0.000755	0.00165	CcSEcCtD
Sevoflurane—Mediastinal disorder—Epirubicin—thyroid cancer	0.000754	0.00165	CcSEcCtD
Sevoflurane—Chills—Epirubicin—thyroid cancer	0.00075	0.00164	CcSEcCtD
Sevoflurane—Arrhythmia—Epirubicin—thyroid cancer	0.000747	0.00163	CcSEcCtD
Sevoflurane—Mental disorder—Epirubicin—thyroid cancer	0.000733	0.0016	CcSEcCtD
Sevoflurane—Malnutrition—Epirubicin—thyroid cancer	0.000728	0.00159	CcSEcCtD
Sevoflurane—Cardiac disorder—Doxorubicin—thyroid cancer	0.000718	0.00157	CcSEcCtD
Sevoflurane—Tension—Epirubicin—thyroid cancer	0.000714	0.00156	CcSEcCtD
Sevoflurane—Dysgeusia—Epirubicin—thyroid cancer	0.000713	0.00156	CcSEcCtD
Sevoflurane—Nervousness—Epirubicin—thyroid cancer	0.000707	0.00155	CcSEcCtD
Sevoflurane—Angiopathy—Doxorubicin—thyroid cancer	0.000702	0.00153	CcSEcCtD
Sevoflurane—Immune system disorder—Doxorubicin—thyroid cancer	0.000699	0.00153	CcSEcCtD
Sevoflurane—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000697	0.00152	CcSEcCtD
Sevoflurane—Chills—Doxorubicin—thyroid cancer	0.000694	0.00152	CcSEcCtD
Sevoflurane—Arrhythmia—Doxorubicin—thyroid cancer	0.000691	0.00151	CcSEcCtD
Sevoflurane—Mental disorder—Doxorubicin—thyroid cancer	0.000678	0.00148	CcSEcCtD
Sevoflurane—Malnutrition—Doxorubicin—thyroid cancer	0.000674	0.00147	CcSEcCtD
Sevoflurane—Agitation—Epirubicin—thyroid cancer	0.000669	0.00146	CcSEcCtD
Sevoflurane—Tension—Doxorubicin—thyroid cancer	0.000661	0.00145	CcSEcCtD
Sevoflurane—Dysgeusia—Doxorubicin—thyroid cancer	0.00066	0.00144	CcSEcCtD
Sevoflurane—Nervousness—Doxorubicin—thyroid cancer	0.000654	0.00143	CcSEcCtD
Sevoflurane—Syncope—Epirubicin—thyroid cancer	0.000653	0.00143	CcSEcCtD
Sevoflurane—Loss of consciousness—Epirubicin—thyroid cancer	0.00064	0.0014	CcSEcCtD
Sevoflurane—Cough—Epirubicin—thyroid cancer	0.000635	0.00139	CcSEcCtD
Sevoflurane—Convulsion—Epirubicin—thyroid cancer	0.000631	0.00138	CcSEcCtD
Sevoflurane—Hypertension—Epirubicin—thyroid cancer	0.000629	0.00137	CcSEcCtD
Sevoflurane—Chest pain—Epirubicin—thyroid cancer	0.00062	0.00136	CcSEcCtD
Sevoflurane—Agitation—Doxorubicin—thyroid cancer	0.000619	0.00135	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000616	0.00135	CcSEcCtD
Sevoflurane—Dry mouth—Epirubicin—thyroid cancer	0.000606	0.00133	CcSEcCtD
Sevoflurane—Syncope—Doxorubicin—thyroid cancer	0.000604	0.00132	CcSEcCtD
Sevoflurane—Confusional state—Epirubicin—thyroid cancer	0.000599	0.00131	CcSEcCtD
Sevoflurane—Anaphylactic shock—Epirubicin—thyroid cancer	0.000594	0.0013	CcSEcCtD
Sevoflurane—Oedema—Epirubicin—thyroid cancer	0.000594	0.0013	CcSEcCtD
Sevoflurane—Loss of consciousness—Doxorubicin—thyroid cancer	0.000592	0.00129	CcSEcCtD
Sevoflurane—Cough—Doxorubicin—thyroid cancer	0.000588	0.00129	CcSEcCtD
Sevoflurane—Shock—Epirubicin—thyroid cancer	0.000585	0.00128	CcSEcCtD
Sevoflurane—Convulsion—Doxorubicin—thyroid cancer	0.000584	0.00128	CcSEcCtD
Sevoflurane—Nervous system disorder—Epirubicin—thyroid cancer	0.000583	0.00127	CcSEcCtD
Sevoflurane—Thrombocytopenia—Epirubicin—thyroid cancer	0.000582	0.00127	CcSEcCtD
Sevoflurane—Hypertension—Doxorubicin—thyroid cancer	0.000582	0.00127	CcSEcCtD
Sevoflurane—Tachycardia—Epirubicin—thyroid cancer	0.00058	0.00127	CcSEcCtD
Sevoflurane—Skin disorder—Epirubicin—thyroid cancer	0.000577	0.00126	CcSEcCtD
Sevoflurane—Chest pain—Doxorubicin—thyroid cancer	0.000574	0.00125	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00057	0.00125	CcSEcCtD
Sevoflurane—Dry mouth—Doxorubicin—thyroid cancer	0.000561	0.00123	CcSEcCtD
Sevoflurane—Hypotension—Epirubicin—thyroid cancer	0.000555	0.00121	CcSEcCtD
Sevoflurane—Confusional state—Doxorubicin—thyroid cancer	0.000554	0.00121	CcSEcCtD
Sevoflurane—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00055	0.0012	CcSEcCtD
Sevoflurane—Oedema—Doxorubicin—thyroid cancer	0.00055	0.0012	CcSEcCtD
Sevoflurane—Shock—Doxorubicin—thyroid cancer	0.000541	0.00118	CcSEcCtD
Sevoflurane—Nervous system disorder—Doxorubicin—thyroid cancer	0.000539	0.00118	CcSEcCtD
Sevoflurane—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000538	0.00118	CcSEcCtD
Sevoflurane—Insomnia—Epirubicin—thyroid cancer	0.000537	0.00117	CcSEcCtD
Sevoflurane—Tachycardia—Doxorubicin—thyroid cancer	0.000537	0.00117	CcSEcCtD
Sevoflurane—Skin disorder—Doxorubicin—thyroid cancer	0.000534	0.00117	CcSEcCtD
Sevoflurane—Dyspnoea—Epirubicin—thyroid cancer	0.00053	0.00116	CcSEcCtD
Sevoflurane—Somnolence—Epirubicin—thyroid cancer	0.000528	0.00115	CcSEcCtD
Sevoflurane—Hypotension—Doxorubicin—thyroid cancer	0.000514	0.00112	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000513	0.00112	CcSEcCtD
Sevoflurane—Pain—Epirubicin—thyroid cancer	0.000508	0.00111	CcSEcCtD
Sevoflurane—Insomnia—Doxorubicin—thyroid cancer	0.000497	0.00109	CcSEcCtD
Sevoflurane—Dyspnoea—Doxorubicin—thyroid cancer	0.00049	0.00107	CcSEcCtD
Sevoflurane—Feeling abnormal—Epirubicin—thyroid cancer	0.00049	0.00107	CcSEcCtD
Sevoflurane—Somnolence—Doxorubicin—thyroid cancer	0.000489	0.00107	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000475	0.00104	CcSEcCtD
Sevoflurane—Urticaria—Epirubicin—thyroid cancer	0.000472	0.00103	CcSEcCtD
Sevoflurane—Pain—Doxorubicin—thyroid cancer	0.00047	0.00103	CcSEcCtD
Sevoflurane—Body temperature increased—Epirubicin—thyroid cancer	0.00047	0.00103	CcSEcCtD
Sevoflurane—Feeling abnormal—Doxorubicin—thyroid cancer	0.000453	0.000991	CcSEcCtD
Sevoflurane—Hypersensitivity—Epirubicin—thyroid cancer	0.000438	0.000957	CcSEcCtD
Sevoflurane—Urticaria—Doxorubicin—thyroid cancer	0.000437	0.000955	CcSEcCtD
Sevoflurane—Body temperature increased—Doxorubicin—thyroid cancer	0.000435	0.00095	CcSEcCtD
Sevoflurane—Asthenia—Epirubicin—thyroid cancer	0.000426	0.000932	CcSEcCtD
Sevoflurane—Pruritus—Epirubicin—thyroid cancer	0.00042	0.000919	CcSEcCtD
Sevoflurane—Hypersensitivity—Doxorubicin—thyroid cancer	0.000405	0.000886	CcSEcCtD
Sevoflurane—Asthenia—Doxorubicin—thyroid cancer	0.000394	0.000862	CcSEcCtD
Sevoflurane—Dizziness—Epirubicin—thyroid cancer	0.000393	0.000859	CcSEcCtD
Sevoflurane—Pruritus—Doxorubicin—thyroid cancer	0.000389	0.00085	CcSEcCtD
Sevoflurane—Vomiting—Epirubicin—thyroid cancer	0.000378	0.000826	CcSEcCtD
Sevoflurane—Rash—Epirubicin—thyroid cancer	0.000375	0.000819	CcSEcCtD
Sevoflurane—Dermatitis—Epirubicin—thyroid cancer	0.000374	0.000818	CcSEcCtD
Sevoflurane—Headache—Epirubicin—thyroid cancer	0.000372	0.000814	CcSEcCtD
Sevoflurane—Dizziness—Doxorubicin—thyroid cancer	0.000364	0.000795	CcSEcCtD
Sevoflurane—Nausea—Epirubicin—thyroid cancer	0.000353	0.000772	CcSEcCtD
Sevoflurane—Vomiting—Doxorubicin—thyroid cancer	0.00035	0.000764	CcSEcCtD
Sevoflurane—Rash—Doxorubicin—thyroid cancer	0.000347	0.000758	CcSEcCtD
Sevoflurane—Dermatitis—Doxorubicin—thyroid cancer	0.000346	0.000757	CcSEcCtD
Sevoflurane—Headache—Doxorubicin—thyroid cancer	0.000344	0.000753	CcSEcCtD
Sevoflurane—Nausea—Doxorubicin—thyroid cancer	0.000327	0.000714	CcSEcCtD
Sevoflurane—GRIA1—Neuronal System—BRAF—thyroid cancer	0.000182	0.00259	CbGpPWpGaD
Sevoflurane—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	0.000181	0.00259	CbGpPWpGaD
Sevoflurane—GABRQ—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.00018	0.00257	CbGpPWpGaD
Sevoflurane—CYP2A6—NRF2 pathway—RXRA—thyroid cancer	0.000176	0.00251	CbGpPWpGaD
Sevoflurane—CYP2A6—Fluoropyrimidine Activity—TP53—thyroid cancer	0.000171	0.00244	CbGpPWpGaD
Sevoflurane—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	0.000166	0.00237	CbGpPWpGaD
Sevoflurane—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	0.000161	0.0023	CbGpPWpGaD
Sevoflurane—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	0.000158	0.00226	CbGpPWpGaD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000158	0.00225	CbGpPWpGaD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—CP—thyroid cancer	0.000158	0.00225	CbGpPWpGaD
Sevoflurane—KCNK18—Neuronal System—HRAS—thyroid cancer	0.000157	0.00223	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—TPR—thyroid cancer	0.000156	0.00223	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—TPR—thyroid cancer	0.000156	0.00223	CbGpPWpGaD
Sevoflurane—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	0.000156	0.00222	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000155	0.00222	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000155	0.00222	CbGpPWpGaD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000155	0.00221	CbGpPWpGaD
Sevoflurane—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	0.000155	0.0022	CbGpPWpGaD
Sevoflurane—CYP2A6—Biological oxidations—RXRA—thyroid cancer	0.000154	0.0022	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PRKAR1A—thyroid cancer	0.000154	0.00219	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PRKAR1A—thyroid cancer	0.000154	0.00219	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000153	0.00218	CbGpPWpGaD
Sevoflurane—CYP2A6—NRF2 pathway—NRG1—thyroid cancer	0.000152	0.00217	CbGpPWpGaD
Sevoflurane—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	0.000152	0.00216	CbGpPWpGaD
Sevoflurane—GABRG3—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000148	0.00211	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000147	0.0021	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—CP—thyroid cancer	0.000147	0.0021	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000147	0.00209	CbGpPWpGaD
Sevoflurane—GABRB1—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000146	0.00208	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000145	0.00207	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—CP—thyroid cancer	0.000145	0.00207	CbGpPWpGaD
Sevoflurane—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	0.000145	0.00207	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000145	0.00206	CbGpPWpGaD
Sevoflurane—GABRQ—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000143	0.00205	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000143	0.00204	CbGpPWpGaD
Sevoflurane—GRIA1—BDNF signaling pathway—HRAS—thyroid cancer	0.000142	0.00202	CbGpPWpGaD
Sevoflurane—GABRA6—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000138	0.00197	CbGpPWpGaD
Sevoflurane—GABRQ—Neuronal System—BRAF—thyroid cancer	0.000138	0.00197	CbGpPWpGaD
Sevoflurane—GABRA4—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000136	0.00194	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000133	0.00189	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—CP—thyroid cancer	0.000133	0.00189	CbGpPWpGaD
Sevoflurane—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	0.000133	0.00189	CbGpPWpGaD
Sevoflurane—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000131	0.00187	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000131	0.00186	CbGpPWpGaD
Sevoflurane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000131	0.00186	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000129	0.00184	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—CP—thyroid cancer	0.000129	0.00184	CbGpPWpGaD
Sevoflurane—KCNK10—Neuronal System—HRAS—thyroid cancer	0.000128	0.00182	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000127	0.00181	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000127	0.00181	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—CP—thyroid cancer	0.000127	0.00181	CbGpPWpGaD
Sevoflurane—GRIA1—BDNF signaling pathway—AKT1—thyroid cancer	0.000125	0.00179	CbGpPWpGaD
Sevoflurane—GABRB2—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000125	0.00178	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000125	0.00178	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000125	0.00178	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—CP—thyroid cancer	0.000125	0.00178	CbGpPWpGaD
Sevoflurane—CYP2B6—Biological oxidations—RXRA—thyroid cancer	0.000124	0.00177	CbGpPWpGaD
Sevoflurane—KCNA1—Neuronal System—HRAS—thyroid cancer	0.000124	0.00177	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000124	0.00176	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—CP—thyroid cancer	0.000124	0.00176	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000123	0.00175	CbGpPWpGaD
Sevoflurane—KCNK2—Neuronal System—HRAS—thyroid cancer	0.000122	0.00174	CbGpPWpGaD
Sevoflurane—CYP2E1—Biological oxidations—RXRA—thyroid cancer	0.000122	0.00174	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000122	0.00174	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—CP—thyroid cancer	0.000121	0.00173	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000121	0.00173	CbGpPWpGaD
Sevoflurane—GABRA5—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000121	0.00173	CbGpPWpGaD
Sevoflurane—GABRQ—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000121	0.00172	CbGpPWpGaD
Sevoflurane—ALB—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00012	0.00171	CbGpPWpGaD
Sevoflurane—ALB—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00012	0.00171	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.00012	0.0017	CbGpPWpGaD
Sevoflurane—GABRA3—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000119	0.0017	CbGpPWpGaD
Sevoflurane—KCNK3—Neuronal System—HRAS—thyroid cancer	0.000119	0.00169	CbGpPWpGaD
Sevoflurane—KCNK9—Neuronal System—HRAS—thyroid cancer	0.000119	0.00169	CbGpPWpGaD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000118	0.00169	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—SLC5A5—thyroid cancer	0.000117	0.00167	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—SLC5A5—thyroid cancer	0.000117	0.00167	CbGpPWpGaD
Sevoflurane—GABRA2—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000117	0.00167	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000116	0.00166	CbGpPWpGaD
Sevoflurane—GABRB3—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000116	0.00166	CbGpPWpGaD
Sevoflurane—GABRG2—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000114	0.00163	CbGpPWpGaD
Sevoflurane—GABRG3—Neuronal System—BRAF—thyroid cancer	0.000114	0.00162	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—MINPP1—thyroid cancer	0.000113	0.00162	CbGpPWpGaD
Sevoflurane—GABRB1—Neuronal System—BRAF—thyroid cancer	0.000112	0.0016	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000111	0.00159	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.00011	0.00157	CbGpPWpGaD
Sevoflurane—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	0.00011	0.00157	CbGpPWpGaD
Sevoflurane—GRIA1—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000109	0.00156	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000109	0.00155	CbGpPWpGaD
Sevoflurane—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000106	0.00152	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000106	0.00151	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000106	0.00151	CbGpPWpGaD
Sevoflurane—GABRA6—Neuronal System—BRAF—thyroid cancer	0.000106	0.00151	CbGpPWpGaD
Sevoflurane—GABRA4—Neuronal System—BRAF—thyroid cancer	0.000104	0.00149	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000104	0.00149	CbGpPWpGaD
Sevoflurane—GABRA1—Transmission across Chemical Synapses—BRAF—thyroid cancer	9.97e-05	0.00142	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	9.94e-05	0.00142	CbGpPWpGaD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—RXRA—thyroid cancer	9.93e-05	0.00142	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—RXRA—thyroid cancer	9.83e-05	0.0014	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—RXRA—thyroid cancer	9.83e-05	0.0014	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	9.78e-05	0.00139	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	9.66e-05	0.00138	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—NDUFA13—thyroid cancer	9.63e-05	0.00137	CbGpPWpGaD
Sevoflurane—GABRB2—Neuronal System—BRAF—thyroid cancer	9.56e-05	0.00136	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	9.49e-05	0.00135	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	9.32e-05	0.00133	CbGpPWpGaD
Sevoflurane—GABRA5—Neuronal System—BRAF—thyroid cancer	9.28e-05	0.00132	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	9.26e-05	0.00132	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—RXRA—thyroid cancer	9.25e-05	0.00132	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—MINPP1—thyroid cancer	9.14e-05	0.0013	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—RXRA—thyroid cancer	9.13e-05	0.0013	CbGpPWpGaD
Sevoflurane—GABRA3—Neuronal System—BRAF—thyroid cancer	9.12e-05	0.0013	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	9.09e-05	0.0013	CbGpPWpGaD
Sevoflurane—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	9.06e-05	0.00129	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CHST14—thyroid cancer	9.05e-05	0.00129	CbGpPWpGaD
Sevoflurane—GABRA2—Neuronal System—BRAF—thyroid cancer	8.96e-05	0.00128	CbGpPWpGaD
Sevoflurane—ALB—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	8.96e-05	0.00128	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—MINPP1—thyroid cancer	8.95e-05	0.00128	CbGpPWpGaD
Sevoflurane—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	8.93e-05	0.00127	CbGpPWpGaD
Sevoflurane—GABRB3—Neuronal System—BRAF—thyroid cancer	8.9e-05	0.00127	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—PTGS2—thyroid cancer	8.89e-05	0.00127	CbGpPWpGaD
Sevoflurane—GABRG2—Neuronal System—BRAF—thyroid cancer	8.74e-05	0.00125	CbGpPWpGaD
Sevoflurane—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	8.45e-05	0.0012	CbGpPWpGaD
Sevoflurane—GRIA1—Neuronal System—HRAS—thyroid cancer	8.36e-05	0.00119	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—RXRA—thyroid cancer	8.35e-05	0.00119	CbGpPWpGaD
Sevoflurane—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	8.34e-05	0.00119	CbGpPWpGaD
Sevoflurane—GABRQ—Transmission across Chemical Synapses—HRAS—thyroid cancer	8.27e-05	0.00118	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—RXRA—thyroid cancer	8.12e-05	0.00116	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.97e-05	0.00114	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	7.95e-05	0.00113	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.83e-05	0.00112	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.78e-05	0.00111	CbGpPWpGaD
Sevoflurane—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	7.78e-05	0.00111	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—NDUFA13—thyroid cancer	7.77e-05	0.00111	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—MINPP1—thyroid cancer	7.69e-05	0.0011	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.64e-05	0.00109	CbGpPWpGaD
Sevoflurane—GABRA1—Neuronal System—BRAF—thyroid cancer	7.64e-05	0.00109	CbGpPWpGaD
Sevoflurane—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	7.63e-05	0.00109	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—NDUFA13—thyroid cancer	7.61e-05	0.00109	CbGpPWpGaD
Sevoflurane—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	7.41e-05	0.00106	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CHST14—thyroid cancer	7.31e-05	0.00104	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—HPGD—thyroid cancer	7.3e-05	0.00104	CbGpPWpGaD
Sevoflurane—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	7.28e-05	0.00104	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CHST14—thyroid cancer	7.16e-05	0.00102	CbGpPWpGaD
Sevoflurane—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	7.15e-05	0.00102	CbGpPWpGaD
Sevoflurane—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	7.1e-05	0.00101	CbGpPWpGaD
Sevoflurane—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	6.98e-05	0.000995	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—HRAS—thyroid cancer	6.95e-05	0.000991	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PRKAR1A—thyroid cancer	6.91e-05	0.000985	CbGpPWpGaD
Sevoflurane—GABRG3—Transmission across Chemical Synapses—HRAS—thyroid cancer	6.81e-05	0.000972	CbGpPWpGaD
Sevoflurane—GABRB1—Transmission across Chemical Synapses—HRAS—thyroid cancer	6.71e-05	0.000957	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.68e-05	0.000953	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—TP53—thyroid cancer	6.66e-05	0.00095	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—NDUFA13—thyroid cancer	6.54e-05	0.000933	CbGpPWpGaD
Sevoflurane—GABRA6—Transmission across Chemical Synapses—HRAS—thyroid cancer	6.35e-05	0.000906	CbGpPWpGaD
Sevoflurane—GABRQ—Neuronal System—HRAS—thyroid cancer	6.34e-05	0.000904	CbGpPWpGaD
Sevoflurane—GABRA4—Transmission across Chemical Synapses—HRAS—thyroid cancer	6.27e-05	0.000894	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PPARG—thyroid cancer	6.21e-05	0.000885	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PPARG—thyroid cancer	6.21e-05	0.000885	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CHST14—thyroid cancer	6.15e-05	0.000877	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—AKT1—thyroid cancer	6.13e-05	0.000875	CbGpPWpGaD
Sevoflurane—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	6.1e-05	0.00087	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—TPR—thyroid cancer	6.08e-05	0.000867	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—CP—thyroid cancer	6.08e-05	0.000867	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	5.98e-05	0.000853	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—HPGD—thyroid cancer	5.89e-05	0.00084	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—HPGD—thyroid cancer	5.77e-05	0.000823	CbGpPWpGaD
Sevoflurane—GABRB2—Transmission across Chemical Synapses—HRAS—thyroid cancer	5.73e-05	0.000818	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—RXRA—thyroid cancer	5.65e-05	0.000806	CbGpPWpGaD
Sevoflurane—GABRA5—Transmission across Chemical Synapses—HRAS—thyroid cancer	5.57e-05	0.000795	CbGpPWpGaD
Sevoflurane—GABRA3—Transmission across Chemical Synapses—HRAS—thyroid cancer	5.47e-05	0.00078	CbGpPWpGaD
Sevoflurane—GABRA2—Transmission across Chemical Synapses—HRAS—thyroid cancer	5.38e-05	0.000767	CbGpPWpGaD
Sevoflurane—GABRB3—Transmission across Chemical Synapses—HRAS—thyroid cancer	5.34e-05	0.000762	CbGpPWpGaD
Sevoflurane—GABRG2—Transmission across Chemical Synapses—HRAS—thyroid cancer	5.24e-05	0.000748	CbGpPWpGaD
Sevoflurane—GABRG3—Neuronal System—HRAS—thyroid cancer	5.22e-05	0.000744	CbGpPWpGaD
Sevoflurane—GABRB1—Neuronal System—HRAS—thyroid cancer	5.14e-05	0.000733	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—HPGD—thyroid cancer	4.96e-05	0.000707	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PTGS2—thyroid cancer	4.88e-05	0.000696	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PTGS2—thyroid cancer	4.88e-05	0.000696	CbGpPWpGaD
Sevoflurane—GABRA6—Neuronal System—HRAS—thyroid cancer	4.86e-05	0.000694	CbGpPWpGaD
Sevoflurane—GABRA4—Neuronal System—HRAS—thyroid cancer	4.8e-05	0.000685	CbGpPWpGaD
Sevoflurane—GABRA1—Transmission across Chemical Synapses—HRAS—thyroid cancer	4.58e-05	0.000654	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—IFNA2—thyroid cancer	4.58e-05	0.000653	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	4.55e-05	0.000649	CbGpPWpGaD
Sevoflurane—GABRB2—Neuronal System—HRAS—thyroid cancer	4.39e-05	0.000627	CbGpPWpGaD
Sevoflurane—GABRA5—Neuronal System—HRAS—thyroid cancer	4.27e-05	0.000609	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PTEN—thyroid cancer	4.26e-05	0.000607	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PTEN—thyroid cancer	4.26e-05	0.000607	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—TPR—thyroid cancer	4.19e-05	0.000598	CbGpPWpGaD
Sevoflurane—GABRA3—Neuronal System—HRAS—thyroid cancer	4.19e-05	0.000598	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—MINPP1—thyroid cancer	4.15e-05	0.000592	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PRKAR1A—thyroid cancer	4.12e-05	0.000588	CbGpPWpGaD
Sevoflurane—GABRA2—Neuronal System—HRAS—thyroid cancer	4.12e-05	0.000588	CbGpPWpGaD
Sevoflurane—GABRB3—Neuronal System—HRAS—thyroid cancer	4.09e-05	0.000584	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.02e-05	0.000574	CbGpPWpGaD
Sevoflurane—GABRG2—Neuronal System—HRAS—thyroid cancer	4.02e-05	0.000573	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.82e-05	0.000545	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—NDUFA13—thyroid cancer	3.53e-05	0.000504	CbGpPWpGaD
Sevoflurane—GABRA1—Neuronal System—HRAS—thyroid cancer	3.51e-05	0.000501	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—TPR—thyroid cancer	3.38e-05	0.000482	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PRKAR1A—thyroid cancer	3.33e-05	0.000475	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CHST14—thyroid cancer	3.32e-05	0.000474	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—TPR—thyroid cancer	3.31e-05	0.000473	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PRKAR1A—thyroid cancer	3.26e-05	0.000465	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—SLC5A5—thyroid cancer	3.14e-05	0.000448	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—TPR—thyroid cancer	2.85e-05	0.000406	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PRKAR1A—thyroid cancer	2.8e-05	0.0004	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—HPGD—thyroid cancer	2.68e-05	0.000382	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—RXRA—thyroid cancer	2.64e-05	0.000376	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.54e-05	0.000362	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—SLC5A5—thyroid cancer	2.53e-05	0.000361	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—SLC5A5—thyroid cancer	2.48e-05	0.000354	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—AKT1—thyroid cancer	2.45e-05	0.00035	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—AKT1—thyroid cancer	2.45e-05	0.00035	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	2.14e-05	0.000305	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—SLC5A5—thyroid cancer	2.13e-05	0.000304	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—RXRA—thyroid cancer	2.13e-05	0.000303	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—RXRA—thyroid cancer	2.08e-05	0.000297	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2e-05	0.000285	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—RXRA—thyroid cancer	1.79e-05	0.000255	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.74e-05	0.000248	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—NRAS—thyroid cancer	1.71e-05	0.000243	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PPARG—thyroid cancer	1.66e-05	0.000237	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—TPR—thyroid cancer	1.54e-05	0.000219	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.51e-05	0.000216	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—KRAS—thyroid cancer	1.47e-05	0.00021	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PPARG—thyroid cancer	1.34e-05	0.000192	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PPARG—thyroid cancer	1.32e-05	0.000188	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PTGS2—thyroid cancer	1.31e-05	0.000187	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—TP53—thyroid cancer	1.31e-05	0.000186	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—HRAS—thyroid cancer	1.25e-05	0.000178	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.15e-05	0.000164	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PTEN—thyroid cancer	1.14e-05	0.000163	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PPARG—thyroid cancer	1.13e-05	0.000161	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—AKT1—thyroid cancer	1.1e-05	0.000157	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PTGS2—thyroid cancer	1.06e-05	0.000151	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PTGS2—thyroid cancer	1.03e-05	0.000148	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—RXRA—thyroid cancer	9.67e-06	0.000138	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PTEN—thyroid cancer	9.21e-06	0.000131	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PTEN—thyroid cancer	9.03e-06	0.000129	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PTGS2—thyroid cancer	8.89e-06	0.000127	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PTEN—thyroid cancer	7.76e-06	0.000111	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—AKT1—thyroid cancer	6.58e-06	9.39e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PPARG—thyroid cancer	6.1e-06	8.71e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—AKT1—thyroid cancer	5.31e-06	7.58e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—AKT1—thyroid cancer	5.2e-06	7.42e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PTGS2—thyroid cancer	4.8e-06	6.85e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—AKT1—thyroid cancer	4.47e-06	6.38e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PTEN—thyroid cancer	4.19e-06	5.97e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—AKT1—thyroid cancer	2.41e-06	3.44e-05	CbGpPWpGaD
